XTSE
AIDX
Market cap148mUSD
, Last price
CAD
Name
MCI Onehealth Technologies Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
45.57%
Rev. 5Y
21.87%
Div Yld LY
—
Div Yld TTM
—
Revenues
104m
+166.14%
Net income
-47m
L+78.37%
CFO
-19m
L-14.21%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Healwell AI Inc., a Toronto-based healthcare technology enterprise established in 2012, specializes in leveraging artificial intelligence and data science to enhance preventative care. The company provides an AI-powered decision support platform tailored for healthcare professionals. Significantly, Healwell AI Inc. also holds a strategic alliance agreement with WELL Health Technologies Corp, a partnership dedicated to accelerating the development and expansion of AI-driven healthcare solutions. The organization officially adopted its current name in October 2023, having previously operated as MCI Onehealth Technologies Inc.
Related entities
Subsidiaries
MCI Medical Clinics Inc.
Key people
Chairman of the Board · since 2023
Anthony Lam
Chief Financial Officer, Corporate Secretary · since 2024
G. Scott Nirenberski
Chief Financial Officer · since 2023
Don Watts
President - Khure Health · since 2022
Blake Corbet
Senior Vice President of Corporate Development, and Capital Markets · since 2024
Kingsley Ward
Lead Independent Director · since 2020
Alexander Dobranowski
Chief Executive Officer, Director, Founder · since 2020
Director · since 2025
Bashar Al-Rehany
Independent Director · since 2020
Erik Danudjaja
Director · since 2025
Independent Director · since 2025
Legal address
1 Yorkdale Road, Suite 209
Toronto, ON M6A 3A1
CA
Toronto, ON M6A 3A1
CA
Headquarters
4881 Yonge Street, Suite 300
Toronto, ON M2N 5X3
CA
Toronto, ON M2N 5X3
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||